| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +4% |
| 3Y CAGR | +13% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +38% |
| 3Y CAGR | +4% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,643.70 +16.10 (0.35%) | 21,168.16 | 28.79 | 5.04 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,845.00 +124.50 (4.58%) | 20,634.90 | 30.43 | 5.75 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,940.50 +72.50 (1.06%) | 17,175.63 | 101.26 | 19.68 | ||
Natco PharmaNATCOPHARM | ₹838.30 -4.95 (0.59%) | 15,100.75 | 13.19 | 1.64 |